On the back of ageing population and spiked diabetic people bracket, the demand for ortho/diabetic shoes is projected to see a great demand in the region. The diabetic footwear market in United States was valued at USD 1112.0 Million in 2015 and it is anticipated that the market would increase at a healthy compound annual growth rate (CAGR) by 2021.
The total population of diabetic patients in the U.S. has augmented from 5.5 million in 1982 to 22.0 million in 2014. Owing to this augmented growth of diabetic population, the risk of foot ulcers and neuropathy has also increased significantly in the previous few years.
Diabetes is also one of the prominent causes of lower limb amputations in the U.S. At present, the U.S. is a home to around 2 million people surviving with amputations (limb losses) and according to an estimate around 185,010 limb losses occurs every year in the U.S. According to the Center for Disease Control and Prevention (CDC), it is estimated that one out of every three adults in the U.S. would suffer from diabetes by the end of 2050. With this rise in number of diabetic cases in the country, the risk of lower limb amputations would also soar in the future.
In order to reduce the chances of amputations caused by diabetes, there is a great need of taking proper feet care measures like wearing right kind of footwear by the people. These measures and practices would surely help to fuel the market of diabetic footwear in the region. The therapeutic/diabetic footwear market in Canada is anticipated to witness a continuous rise in the year-on-year (y-o-y) growth rate from 4.6% in 2015 to 6.5% in 2017. However, the diabetic shoes demand growth rate is expected to decline by 0.8 percentage points from 7.09% in 2020 to 6.3% in 2021.
The report studies the demand on the basis of inpatient and outpatient in the region which further has been granule to the country data. In addition to that, to understand the most profitable distribution mode in the region, the market for U.S., Canada & Mexico has been studied based on the online & offline channels. Offline distribution channels further have been studied into specialty store, clinics & street stores.
Key Answers Captured in Report
- Which geography would have better demand for product/services?
- What are the strategies adopted by big players in the regional market?
- Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
- What is the current & expected market size in next five years?
- What is the market feasibility for long term investment?
- What opportunity the country would offer for existing and new players in the market?
- What is risk involved for suppliers in the geography?
- What factors would drive the demand for the product/service in near future?
- What is the impact analysis of various factors in the market growth?
- What are the recent trends in the regional market and how successful they are?
1. List of Figures & Tables
2. Executive Summary6
3. Market Entry & Winning Strategy
4. Research Methodology
5. Global Diabetic Footwear Market Size and Forecast
6. Market Segmentation
6.1 By Region
6.1.1 North America Market Size & Y-O-Y % growth, 2015-2021
22.214.171.124 U.S Market Size & Y-O-Y % growth, 2015-2021
126.96.36.199.1 By Demography Market Size & Y-O-Y % growth, 2015-2021
188.8.131.52.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021
184.108.40.206.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021
220.127.116.11 Canada Market Size & Y-O-Y % growth, 2015-2021
18.104.22.168.1 By Demography Market Size & Y-O-Y % growth, 2015-2021
22.214.171.124.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021
126.96.36.199.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021
188.8.131.52 Mexico Market Size & Y-O-Y % growth, 2015-2021
184.108.40.206.1 By Demography Market Size & Y-O-Y % growth, 2015-2021
220.127.116.11.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021
18.104.22.168.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021
6.1.2 Y-O-Y % Growth Comparison by Country
6.1.3 North America Base Point Scale (BPS) Analysis- By Demography
6.1.3 North America Base Point Scale (BPS) Analysis- By Inpatient & Outpatient
6.1.3 North America Base Point Scale (BPS) Analysis- By Retail Distribution
6.1.4 North America Market Attractiveness-By Country
6.1.4 North America Market Attractiveness-By Distribution Channel
6.2 North America Segmentation By Demography Market Size & Y-O-Y % growth, 2015-2021
6.3 North America By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021
6.4 North America By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021
7. Porter’s Five Force Model Analysis
8. Industry Growth Drivers
8.1 Rise in prevalence of diabetes in North America
8.1.1 Impact Analysis
8.2 Growth in the aging population
8.2.1 Impact Analysis
8.3 Increasing demand of customized diabetic footwear
8.3.1 Impact Analysis
8.4 Rise in spending on diabetes treatment
8.4.1 Impact Analysis
9.1 High cost of diabetic footwear
9.1.1 Impact Analysis
9.2 Lack of awareness
9.2.1 Impact Analysis
10. Risk Analysis
10.1 Supply Risk - Medium
10.2 Demand Risk - Medium
11. Competitive Landscape
11.1 DARCO International Inc.
11.1.1 Company Overview
11.1.2 Products and Services
11.1.3 Key Financials
11.1.4 Recent News and Developments
11.2.1 Company Overview
11.2.2 Products and services
11.2.3 Key Financials
11.2.4 Recent News and Developments
11.3 Ortho Europe
11.3.1 Company Overview
11.3.2 Products and Services
11.3.3 Key Financials
11.3.4 Recent news and developments
11.4 Duna Srl
11.4.1 Company Overview
11.4.2 Products and services
11.4.3 Key Financials
11.4.4 Recent News & Developments
11.5.1 Company Overview
11.5.2 Products and Services
11.5.3 Key Financials
11.5.4 Recent news & developments
11.6 Medline Industries
11.6.1 Company Overview
11.6.2 Products and services
11.6.3 Key Financials
11.6.4 Recent news & developments
11.7 DJO Global Inc
11.7.1 Company Overview
11.7.2 Products and services
11.7.3 Key Financials
11.7.4 Recent news & developments
11.8 Hong Kong Grace Shoes Development Co Ltd.
11.8.1 Company Overview
11.8.2 Products and services
11.8.3 Key Financials
11.8.4 Recent news & developments
11.9 Dr. Zen Inc
11.9.1 Company Overview
11.9.2 Products and services
11.9. 3 Key Financials
11.9.4 Recent news & developments
11.10.1 Company Overview
11.10.2 Products and services
11.10.3 Key Financials
11.10.4 Recent news & developments
11.11 Drew Shoe Corporation USA
11.11.1 Company Overview
11.11.2 Products and Services
11.11.3 Key Financials
11.11.4 Recent news & developments
11.12 Podartis Srl
11.12.1 Company Overview
11.12.2 Products and Services
11.12.3 Key Financials
11.12.4 Recent news & developments
11.13 Aetrex Worldwide, Inc.
11.13.1 Company overview
11.13.2 Products and Services
11.13.3 Key Financials
11.13.4 Recent news & developments
List of Tables
Table 5-1: Ranking of countries in terms of adult (age 20-79 years) diabetic population (in millions) in 2015 and 2040
Table 5-2: Ranking of countries in terms of diabetes related health expenditure (USD Billions) in 2015 and 2040
Table 6-1: Diabetes prevalence % in major countries of U.K. (2012-13) 22
Table 11-1: DJO Global key financials (USD Millions), 2012-2014
Table 11-2: DJO Global net sales by products (USD Millions), 2012-2014
Table 11-3: DJO Global net sales by country (USD Millions), 2012-2014" "1. List of Figures
List of Figures
Figure 5-1: Global Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 5-2: Total number of diabetic patients (age 20-79 years) in the world
Figure 6-1: The U.S. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-2: Number of diabetic population (in millions) in the U.S., 2010-2014
Figure 6-3: Major causes of amputations in U.S.
Figure 6-4: Canada Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-5: Total number of diabetic patients in Canada (age > 12)
Figure 6-6: Total health expenditure (USD Millions) in Canada during 2010-2014
Figure 6-7: Mexico Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-8: Total number of diabetic patients in Mexico (age 20-79 years), 2014-2021
Figure 6-9: North America Market Attractiveness
Figure 6-10: North America BPS Analysis
Figure 6-48: % market share by demography in 2014
Figure 6-49: % market share by demography in 2021
Figure 6-50: % of male and female diabetic population in the U.S.
Figure 6-51: % of male and female diabetic population in Canada
Figure 6-52: % of male and female diabetic population in Mexico(age>25)
Figure 6-53: % of male and female diabetic population in the United Kingdom
Figure 6-54: % of male and female diabetic population in India
Figure 6-55: % of adult male and female diabetic population in China
Figure 6-56: % market share by inpatient and outpatient in 2014
Figure 6-57: % market share by inpatient and outpatient in 2021
Figure 6-58: Annual health spending (per capita) % growth in Germany
Figure 6-59: % market share by retail distribution in 2014
Figure 6-60: % market share by retail distribution in 2021
Figure 6-61: % market share by medical specialty and street stores in 2014
Figure 6-62: % market share by medical specialty and street stores in 2021
Figure 6-63: Sales of online stores in the U.S. from 2014-2016E (USD Billions)
Figure 6-64: Sales of departmental stores in the U.S. (USD Billions) during 2011-2015
Figure 6-65: % share of online retail outlets in North America by country in 2015
Figure 6-66: E-commerce % share of total retail sales, India and China (2013-2017)
Figure 6-67: E-commerce market size in Brazil, Argentina and Mexico, forecast to 2019
Figure 7-1: Porter`s Five Force Model, 2016
- Aetrex Worldwide, Inc.
- DARCO International Inc.
- DJO Global Inc
- Dr. Zen Inc
- Drew Shoe Corporation USA
- Duna Srl
- Hong Kong Grace Shoes Development Co Ltd.
- Medline Industries
- Ortho Europe
- Podartis Srl